Tang Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Tang Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,353,307	Closed	-$11.7M	–	184
2025 Q3	$11.7M	Hold	2,353,307	–	–	0.45%	55
2025 Q2	$11.1M	Hold	2,353,307	–	–	0.56%	47
2025 Q1	$10.8M	Hold	2,353,307	–	–	0.6%	45
2024 Q4	$11.3M	Hold	2,353,307	–	–	0.75%	37
2024 Q3	$11M	Buy	2,353,307 +200,000	+9%	+$1.07M	0.79%	43
2024 Q2	$12.2M	Buy	2,153,307 +401,653	+23%	+$2.07M	1.24%	26
2024 Q1	$7.2M	Buy	1,751,654 +1,503,464	+606%	+$6.02M	0.75%	47
2023 Q4	$1.05M	Buy	+248,190	New	+$1M	0.1%	105
2023 Q2	–	Sell	-100,000	Closed	-$679K	–	114
2023 Q1	$679K	Buy	+100,000	New	+$703K	0.1%	83
2022 Q4	–	Sell	-256,696	Closed	-$2.54M	–	105
2022 Q3	$2.54M	Hold	256,696	–	–	0.31%	66
2022 Q2	$2.8M	Hold	256,696	–	–	0.42%	45
2022 Q1	$2.9M	Buy	+256,696	New	+$3.37M	0.58%	41
2020 Q4	–	Sell	-191,426	Closed	-$1.85M	–	20
2020 Q3	$1.85M	Hold	191,426	–	–	0.33%	17
2020 Q2	$2.19M	Sell	191,426 -108,374	-36%	-$1.23M	0.21%	18
2020 Q1	$3.11M	Buy	+299,800	New	+$3.72M	0.44%	18

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Tang Capital Management's VNDA Position: Q4 2025 in Review

Tang Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2025, closing a stake of 2,353,307 shares — an estimated $11.7M sold.

Tang Capital Management first reported a position in VNDA in Q1 2020 and held it in 15 quarters. The position peaked at $12.2M in Q2 2024. 153 funds tracked by Wall St. Rank hold VNDA as of Q4 2025.

Tang Capital Management reported no remaining Vanda Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Tang Capital Management sold 2,353,307 Vanda Pharmaceuticals shares in Q4 2025, an estimated $11.7M.
Tang Capital Management first reported a position in Vanda Pharmaceuticals in Q1 2020 and held it in 15 quarters.
Tang Capital Management's Vanda Pharmaceuticals position peaked at $12.2M in Q2 2024.
153 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.